Influenza A virus is a member of the Orthomyxoviridae family and is responsible for seasonal flu outbreaks in humans. The virus has a segmented RNA genome, allowing for frequent genetic reassortment, which contributes to the phenomenon of antigenic variation. Antigenic variation involves changes in the viral surface proteins, hemagglutinin (HA) and neuraminidase (NA), leading to the classification of influenza A viruses into subtypes based on these proteins. Currently, there are 18 HA subtypes and 11 NA subtypes, resulting in a diverse pool of influenza A viruses circulating in animal reservoirs, particularly birds and swine. Seasonal influenza outbreaks occur annually, with the virus causing respiratory infections characterized by symptoms such as fever, cough, and body aches. The ability of influenza A to undergo antigenic drift, subtle changes in the viral surface proteins over time, necessitates the regular updating of influenza vaccines to match the circulating strains. This dynamic process of antigenic variation contributes to the challenges in predicting and preventing influenza outbreaks. Public health measures, including vaccination, antiviral medications, and hygiene practices, play a crucial role in mitigating the impact of seasonal influenza A outbreaks. Global surveillance efforts, such as those led by the World Health Organization (WHO), monitor circulating influenza strains to inform vaccine composition and guide public health responses to emerging threats, such as potential pandemics.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain